G. Stamatakos, the Father of In Silico Medicine, chairs the In Silico Oncology Track at the VPH 2026 - 9th International Conference on the Virtual Physiological Human, Milan, Italy, 1-4 September 2026 - CALL FOR ABSTRACTS

I am pleased to share that I will be chairing the track "In Silico Oncology" at the conference VPH 2026 (Virtual Physiological Human 2026). The conference will be held in Milan, Italy from 1 to 4 September 2026. I am looking forward to engaging discussions and high-quality contributions! [Click the blue text below to visit the corresponding webpage or to download the corresponding article.] Abstract submissions are now open until March 2. 🔗 https://vph-conference.org/abstract-submission/ 📌 SAVE THE DATE 9th International Conference on the Virtual Physiological Human (VPH) 📍 September 1–4, Politecnico di Milano 🔗 https://vph-conference.org/ It is worth noting that in silico oncology in its form of in silico radiation oncology served as the concrete paradigm for the formal foundation of in silico medicine as a distinct discipline in 2002 through the publication Stamatakos et al., "In silico radiation oncology: combining novel simulation algorithms with current visualization techniques," in Proceedings of the IEEE, vol. 90, no. 11, pp. 1764-1777, Nov. 2002, doi: 10.1109/JPROC.2002.804685, https://ieeexplore.ieee.org/document/1046955). The open access accepted manuscript of the paper is available at https://zenodo.org/records/18317236 . Proceedings of the IEEE is a top-tier, peer-reviewed technology journal. More information on the emergence and formalization of in silico medicine and digital (virtual) twins in oncology and beyond is available in Stamatakos, G. (2026). History of the emergence and formalization of in silico medicine. Zenodo. https://doi.org/10.5281/zenodo.18328392 . Relevant Resource Link to the graphics video titled “Episode 9: Beating childhood cancer with in silico medicine” (2025). The video focuses on the use of the digital twin (virtual human twin) “Oncosimulator” in pediatric oncology for the individualization and optimization of cancer treatment through the conduct of in silico experiments (experiments on the computer) i.e. through in silico oncology: https://www.youtube.com/watch?v=SCIpzxq8zW4 Research Professor Georgios S. Stamatakos Father of In Silico Medicine https://doi.org/10.5281/zenodo.18328392 Institute of Communication and Computer Systems (ICCS) School of Electrical and Computer Engineering (ECE) National Technical University of Athens (NTUA) Director and Founder, In Silico Oncology and In Silico Medicine Group, ICCS, ECE, NTUA Visiting Professor, Medical School, University of Saarland, Germany (1/7–15/9/2019) Visiting Professor, ECE, NTUA (2016-2019) Co-Chair, Cancer and In Silico Oncology Task Force, Avicenna Alliance - Association for Predictive Medicine Editor, Scientific Reports, Nature Portfolio Iroon Polytechniou 9, GR 157 80 Zografos, Greece E-Mail: gestam@central.ntua.gr , Tel. +30 210 7722287, www.in-silico-oncology.iccs.ntua.gr